MNRR1 is a driver of ovarian cancer progression
Cancer progression requires the acquisition of mechanisms that support proliferative potential and metastatic capacity. MNRR1 (also CHCHD2, PARK22, AAG10) is a bi-organellar protein that in the mitochondria can bind to Bcl-xL to enhance its anti-apoptotic function, or to respiratory chain complex IV...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2023-03-01
|
| Sarja: | Translational Oncology |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S1936523323000086 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
